Literature DB >> 10527690

Expression of extracellular matrix ligands and receptors in the muscular tissue and draining lymph nodes of mdx dystrophic mice.

J Lagrota-Cândido1, I Canella, W Savino, T Quirico-Santos.   

Abstract

The mdx mouse, an animal model of Duchenne muscular dystrophy, develops an X-linked recessive inflammatory myopathy. During onset of disease and height of myonecrosis, mdx mice also display important changes in the microenvironment of lymphoid tissues. Draining lymph nodes showed reduced cellularity and atrophy accompanied by intense immunolabeling for fibronectin, laminin, and type-IV collagen. Following clinical amelioration of dystrophy, mdx mice showed enhanced cellularity and a consistent increase in the absolute numbers of CD4(+) and CD8(+) cells expressing alpha4(high) and alpha5(high) extracellular matrix receptors. Furthermore, infiltrating cells in the proximity of myonecrosis expressed alpha4, alpha5, and alpha6 integrin chains during both height of myonecrosis and muscular tissue regeneration. Such results indicate that during distinct phases of muscular dystrophy, altered expression of extracellular matrix ligands and receptors may be influencing myonecrosis by promoting adhesion and migration of mononuclear cells into the altered skeletal muscle and toward local draining lymphoid tissue. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10527690     DOI: 10.1006/clim.1999.4749

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  4 in total

1.  Resolution of skeletal muscle inflammation in mdx dystrophic mouse is accompanied by increased immunoglobulin and interferon-gamma production.

Authors:  Jussara Lagrota-Candido; Rita Vasconcellos; Marta Cavalcanti; Marcelo Bozza; Wilson Savino; Thereza Quirico-Santos
Journal:  Int J Exp Pathol       Date:  2002-06       Impact factor: 1.925

Review 2.  Immune-mediated mechanisms potentially regulate the disease time-course of duchenne muscular dystrophy and provide targets for therapeutic intervention.

Authors:  Nicholas P Evans; Sarah A Misyak; John L Robertson; Josep Bassaganya-Riera; Robert W Grange
Journal:  PM R       Date:  2009-08       Impact factor: 2.298

3.  Gender dimorphism influences extracellular matrix expression and regeneration of muscular tissue in mdx dystrophic mice.

Authors:  Maria Cristina Salimena; Jussara Lagrota-Candido; Thereza Quírico-Santos
Journal:  Histochem Cell Biol       Date:  2004-09-28       Impact factor: 4.304

4.  CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy.

Authors:  Fernanda Pinto-Mariz; Luciana Rodrigues Carvalho; Alexandra Prufer De Queiroz Campos Araujo; Wallace De Mello; Márcia Gonçalves Ribeiro; Maria Do Carmo Soares Alves Cunha; Pedro Hernan Cabello; Ingo Riederer; Elisa Negroni; Isabelle Desguerre; Mariana Veras; Erica Yada; Yves Allenbach; Olivier Benveniste; Thomas Voit; Vincent Mouly; Suse Dayse Silva-Barbosa; Gillian Butler-Browne; Wilson Savino
Journal:  Skelet Muscle       Date:  2015-12-10       Impact factor: 4.912

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.